Systematic review of131I combined with lithium carbonate and 131I alone in the treatment of hyperthyroidism
|更新时间:2025-09-11
|
Systematic review of131I combined with lithium carbonate and 131I alone in the treatment of hyperthyroidism
Journal of Chongqing Medical UniversityVol. 47, Issue 6, Pages: 657-661(2022)
作者机构:
中国中医科学院研究生院,北京,100700
作者简介:
基金信息:
DOI:
CLC:R927.2
Published:2022
稿件说明:
移动端阅览
Zhang Xuexue. Systematic review of131I combined with lithium carbonate and 131I alone in the treatment of hyperthyroidism[J]. Journal of chongqing medical university, 2022, 47(6): 657-661.
DOI:
Zhang Xuexue. Systematic review of131I combined with lithium carbonate and 131I alone in the treatment of hyperthyroidism[J]. Journal of chongqing medical university, 2022, 47(6): 657-661.DOI:
Systematic review of131I combined with lithium carbonate and 131I alone in the treatment of hyperthyroidism
Objective: To evaluate whether131I combined with lithium carbonate is better than131I alone in the treatment of hyperthyroidism. Methods: The literature published before April 2020 in PubMed
Web of Science
the Cochrane Library
CNKI
CBM and Wanfang databases was retrieved. Randomized controlled trials (RCTs) of131I combined with lithium carbonate and131I alone in the treatment of hyperthyroidism were searched. The risk bias evaluation tool recommended by Cochrane system evaluation manual was used to evaluate the quality of the included literature
and Review Manager 5.3 was used to perform Meta-analysis on the extracted data
while descriptive analysis was used for those that could not be combined. Results: This study included 14 RCTs for analysis
including 1 567 patients
808 in the experimental group and 759 in the control group. The results showed that there was significant difference in the cure rate of hyperthyroidism between131I combined with lithium carbonate and131I alone at the third month (RR=1.24
95% CI=1.09-1.41
P=0.001) and 12th month (RR=1.18
95% CI=1.04-1.34
P=0.010). There was significant difference in the recurrence rate of hyperthyroidism at the third month (RR=0.39
95% CI=0.18-0.85
P=0.02)
and the incidence of hypothyroidism in one month (RR=1.39
95% CI=1.06-1.84
P=0.02)
and no significant difference in the total effective rate of hyperthyroidism treatment at the third month (RR=1.02
95% CI=0.97-1.08
P=0.48) and sixth month (RR=1.06
95% CI=0.86-1.30
P=0.60). There was no significant difference in thyroid size at 1 month (SMD=-0.26
95% CI=-0.61-0.09
P=0.15). Conclusion: The results of systematic review show that131I combined with lithium carbonate in the treatment of hyperthyroidism
the cure rate
recurrence rate of hyperthyroidism in the third and 12th month and the incidence of hypothyroidism in the 12th month are better than those of131I alone
but there is no significant difference in the total effectiverateandthyroidsizeof hyperthyroidism treatment. However
due to the low quality of the included literature
its results and conclusions still need to be verified by more RCTs with large samples
Paclitaxel/oxaliplatin versus paclitaxel/cisplatin for advanced non-small cell lung cancer:a Meta analysis of randomized controlled trial
Tolvaptan for heart failure:a systematic review
Radiotherapy combined with thermotherapy for treating patients with rectal cancer:a systematic review
Efficacy and safety of one-stage flexible ureteroscopic lithotripsy without ureteral access sheath or ureteral stent in treatment of upper ureteral calculi and renal calculi with a long diameter of ≤10 mm
Related Author
Wang Jingya
Long Rui
Wang Hongmei
Chen Hong
Qiu Feng
Yuan Chaobo
Bai Haiyuan
Zhu Hai
Related Institution
Department of Respiratory,The First Affiliated Hospital of Chongqing Medical University
Department of Pharmacy
Department of Cardiology,the First Hospital of Lanzhou University
Department of General Surgery,The First Clinical Medical College of Lanzhou University
2. Evidence Based Medicine Center of Lanzhou University